Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Jul 16, 2020 12:51PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Maybe those were silly questions I asked but if could someone fill me on how & why these otc shares can hav this sort of effect on our shares that can't be traded?